The DOI matches its Crossref record; 150 of the 153 references it cites were found in a registry or an index.
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Abstract
The INK4b-ARF-INK4a locus encodes two members of the INK4 family of cyclin-dependent kinase inhibitors, p15(INK4b) and p16(INK4a), and a completely unrelated protein, known as ARF. All three products participate in major tumour suppressor networks that are disabled in human cancer and influence key physiological processes such as replicative senescence, apoptosis and stem-cell self-renewal. Transcription from the locus is therefore kept under strict control. Mounting evidence suggests that although the individual genes can respond independently to positive and negative signals in different contexts, the entire locus might be coordinately suppressed by a cis-acting regulatory domain or by the action of Polycomb group repressor complexes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most cancers harbor mutations in one or both of these pathways [ 14 , 15 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [15]
In the citing paper
“This crucial role is evident from the fact that loss of the p16INK4A gene or inherited mutations within it have been frequently related to several human cancers particularly malignant melanoma (Gil and Peters, 2006; Kim and Sharpless, 2006; Li et al., 2011).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Gil and Peters, 2006
In the citing paper
“Epigenetic regulation of the INK4/ARF locus is not limited to polycomb proteins as other epigenetic regulators such as ZRF, MLL1 or JMJD3 are also involved in its regulation (Gil and Peters, 2006; Agger et al., 2009; Barradas et al., 2009; Kotake et al., 2009; Ribeiro et al., 2013).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Gil and Peters, 2006
In the citing paper
“INK4/ARF locus encodes three tumor suppressors namely p16INK4A and p14ARF encoded by CDKN2A gene and p15INK4B by CDKN2B gene (Sharpless, 2005; Gil and Peters, 2006).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Gil and Peters, 2006
In the citing paper
“In contrast, p14ARF establishes cross talk between the p53 and pRB pathways by regulating the stability of p53 by binding to and inhibiting MDM2, responsible for its proteasome-mediated degradation (Gil and Peters, 2006; Kim and Sharpless, 2006).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Gil and Peters, 2006
In the citing paper
“In agreement with p16's role as a guardian of senescence, mutations, silencing or loss of CDKN2A, the gene encoding p16, facilitate senescence bypass and it is frequently associated with carcinogenesis (reviewed in.51,52”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [51]
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
González, S., Klatt, P., Delgado, S., Conde, E., López‐Ríos, F., Sánchez‐Céspedes, M., Méndez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Importantly, oncogenic signalling can elicit a senescence-like arrest that is attributable to effects on the INK4b–ARF–INK4a locus, whether direct or indirec”
BackgroundProliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 3,417
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,568
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,296
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Flagged first, then by citations
3 of the 153 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 844
CDK4/6 inhibitors in breast cancer
Dukelow, T., Kishan, D., Khasraw, M., & Murphy, C. G. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000249 · Cited by 49
Wu, X., Bekker-Jensen, I. H., Christensen, J. F., Rasmussen, K. D., Sidoli, S., Qi, Y., Kong, Y., Wang, X., Cui, Y., Xiao, Z., et al. (2015) · Cell Research · doi:10.1038/cr.2015.121 · Cited by 50
Kawamura, H., Nakatsuka, R., Matsuoka, Y., Sumide, K., Fujioka, T., Asano, H., Iida, H., & Sonoda, Y. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.030 · Cited by 49
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer
Deng, H., Guan, X., Gong, L., Zeng, J., Zhang, H., Chen, M. Y., & Li, G. (2019) · Scientific Reports · doi:10.1038/s41598-018-36560-4 · Cited by 49
Xie, L., Zhang, Q., Mao, J., Zhang, J., & Li, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.680713 · Cited by 50
Molecular role of the PAX5‐ETV6 oncoprotein in promoting B‐cell acute lymphoblastic leukemia
Smeenk, L., Fischer, M., Jurado, S., Jaritz, M., Azaryan, A., Werner, B., Roth, M., Zuber, J. A., Stanulla, M., den Boer, M. L., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695495 · Cited by 48
The paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 50
Oxidative stress and cell senescence as drivers of ageing: Chicken and egg
von Zglinicki, T. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102558 · Cited by 57
BAG3 controls angiogenesis through regulation of ERK phosphorylation
Falco, A., Festa, M., Basile, A. M., Rosati, A., Pascale, M. C., Florenzano, F., Nori, S. L., Nicolin, V., Benedetto, M. D., Vecchione, M. L., et al. (2012) · Oncogene · doi:10.1038/onc.2012.17 · Cited by 47
Geissler, K. H., & Zach, O. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1435-0 · Cited by 51
Wan, X., Yeung, C. L., Kim, S. Y., Dolan, J. G., Ngo, V. N., Burkett, S. S., Khan, J. I., Staudt, L. M., & Helman, L. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1991 · Cited by 48
Melanomagenesis: Overcoming the barrier of melanocyte senescence
Ha, L., Merlino, G. T., & Sviderskaya, E. V. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6230 · Cited by 50
Li, Q., Bai, L., Dong, C., Wang, Y., & Li, Q. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.023 · Cited by 47
Yang, J., Gu, L., Guo, X., Huang, J., Chen, Z., Huang, G., Kang, Y., Zhang, X., Long, J., & Su, L. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0593-6 · Cited by 47
Long Non-Coding RNAs in Haematological Malignancies
Garitano-Trojaola, A., Agirre, X., Prósper, F., & Fortes, P. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140815386 · Cited by 50
Gong, L., Zhang, D., Dong, Y., Lei, Y., Qian, Y., Tan, X., Han, S., & Wang, J. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.11.001 · Cited by 46
de Jonge, H. J. M., de Bont, E. S. J. M., Valk, P. J. M., Schuringa, J. J., Kies, M. P., Woolthuis, C. M., Delwel, R., Veeger, N. J. G. M., Vellenga, E., Löwenberg, B., et al. (2009) · Blood · doi:10.1182/blood-2009-03-212688 · Cited by 46
CLCA2 as a p53-Inducible Senescence Mediator
Tanikawa, C., Nakagawa, H., Furukawa, Y., Nakamura, Y., & Matsuda, K. (2012) · Neoplasia · doi:10.1593/neo.111700 · Cited by 45
Barnhill, L. M., Williams, R. T., Cohen, O., Kim, Y.-J., Batova, A., Mielke, J. A., Messer, K. S., Pu, M., Bao, L., Yu, A. L.-T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3447 · Cited by 46
Carlos, A. R., Escandell, J. M., Kotsantis, P., Suwaki, N., Bouwman, P., Badie, S., Folio, C., Benitez, J. J., Goméz-López, G., Pisano, D. G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3697 · Cited by 47
Wu, J., Kumar, S., Wang, F., Wang, H., Chen, L., Arsenault, P., Mattern, M. R., & Weinstock, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00498 · Cited by 47
Epigenetic control of skin and hair regeneration after wounding
Plikus, M. V., Guerrero‐Juarez, C. F., Treffeisen, E. R., & Gay, D. L. (2014) · Experimental Dermatology · doi:10.1111/exd.12488 · Cited by 47
Wolyniec, K., Wotton, S., Kilbey, A., Jenkins, A., Terry, A., Peters, G., Stocking, C., Cameron, E. R., & Neil, J. C. (2009) · Oncogene · doi:10.1038/onc.2009.101 · Cited by 45
Self-citationShaping the Genome with Non-Coding RNAs
Wang, X. Q. D., Crutchley, J. L., & Dostie, J. (2011) · Current Genomics · doi:10.2174/138920211796429772 · Cited by 46
CDKN2B methylation is associated with carotid artery calcification in ischemic stroke patients
Zhou, S., Zhang, Y., Wang, L., Zhang, Z., Cai, B., Liu, K., Zhang, H., Dai, M., Sun, L., Xu, X., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1093-4 · Cited by 44
Hirosue, A., Ishihara, K., Tokunaga, K., Watanabe, T., Saitoh, N., Nakamoto, M., Chandra, T., Narita, M., Shinohara, M., & Nakao, M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00809.x · Cited by 44
Life and death in hematopoietic stem cells
Oguro, H., & Iwama, A. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.05.001 · Cited by 46
Nullifying the CDKN2AB Locus Promotes Mutant K-ras Lung Tumorigenesis
Schuster, K., Venkateswaran, N., Rabellino, A., Girard, L., Peña‐Llopis, S., & Scaglioni, P. P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0620-t · Cited by 43
Hubberten, M., Bochenek, G., Chen, H., Häsler, R., Wiehe, R., Rosenstiel, P. C., Jepsen, S. V., Dommisch, H., & Schäefer, A. S. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0210-7 · Cited by 43
Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood
Novara, F., Beri, S., Bernardo, M. E., Bellazzi, R., Malovini, A. L., Ciccone, R., Cometa, A. M., Locatelli, F., Giorda, R., & Zuffardi, O. (2009) · Human Genetics · doi:10.1007/s00439-009-0689-7 · Cited by 43
Dulic, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_2 · Cited by 42
Genetic Mechanisms Mediating Atherosclerosis Susceptibility at the Chromosome 9p21 Locus
Cunnington, M. S., & Keavney, B. D. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0178-z · Cited by 43
Ewing, S. J., Zhu, S., Zhu, F., House, J. S., & Smart, R. C. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.105 · Cited by 41
The E3 Ubiquitin Ligase Activity of Trip12 Is Essential for Mouse Embryogenesis
Kajiro, M., Tsuchiya, M., Kawabe, Y.-I., Furumai, R., Iwasaki, N., Hayashi, Y., Katano, M., Nakajima, Y., Goto, N., Watanabe, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025871 · Cited by 45
Long Noncoding RNAs at the Crossroads of Cell Cycle and Genome Integrity
Guiducci, G., & Stojic, L. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.01.006 · Cited by 43
ZRF1 controls oncogene-induced senescence through the INK4-ARF locus
Ribeiro, J. D., Morey, L., Mas, A., Gutierrez, A., Luis, N. M., Mejetta, S., Richly, H., Benitah, S. A., Keyes, W. M., & Di Croce, L. (2013) · Oncogene · doi:10.1038/onc.2012.241 · Cited by 41
Chromosome 9p21 primary open‐angle glaucoma susceptibility locus: a review
Ng, S. K., Casson, R. J., Burdon, K. P., & Craig, J. E. (2013) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12234 · Cited by 41
Effects of rhein lysinate on D-galactose-induced aging mice
Zhen, Y., Lin, Y., Li, K., ZHANG, G.-L., ZHAO, Y.-F., Wang, M., Jing-bo, W., Wei, J., & Hu, G. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2858 · Cited by 41
ARF induction in response to DNA strand breaks is regulated by PARP1
Orlando, G., Khoronenkova, S. V., Dianova, I. I., Parsons, J. L., & Dianov, G. L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1185 · Cited by 43
Noncoding RNAs in Cancer Development
Lin, C., & He, L. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034443 · Cited by 42
The emerging role of long non-coding RNA in gallbladder cancer pathogenesis
Khandelwal, A., Malhotra, A., Jain, M., Vásquez, K. M., & Jain, A. (2016) · Biochimie · doi:10.1016/j.biochi.2016.11.007 · Cited by 41
A Non-Tumor Suppressor Role for Basal p19ARF in Maintaining Nucleolar Structure and Function
Apicelli, A. J., Maggi, L. B., Hirbe, A. C., Miceli, A. P., Olanich, M. E., Winkeler, C. L., Saporita, A. J., Kuchenreuther, M., Sanchez, J., Weilbaecher, K. N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-07 · Cited by 41
Lung, M. L., Dai, W., & Ko, J. M. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814936-2.00002-x · Cited by 46
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 46
High OCT4 and Low p16 INK4A Expressions Determine In Vitro Lifespan of Mesenchymal Stem Cells
Piccinato, C. D. A., Sertie, A. L., Torres, N., Ferretti, M., & Antonioli, E. (2015) · Stem Cells International · doi:10.1155/2015/369828 · Cited by 42
The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability
Fitieh, A. M., Locke, A. J., Motamedi, M., & Ismail, I. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062976 · Cited by 43
CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation
Zhang, P., Gao, K., Zhang, L., Sun, H., Zhao, X., Liu, Y., Lv, Z., Shi, Q., Chen, Y., Jiao, D., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00890-0 · Cited by 39
Mirzakhani, K., Kallenbach, J., Rasa, S. M. M., Ribaudo, F., Ungelenk, M., Ehsani, M., Gong, W., Gaßler, N., Leeder, M., Grimm, M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02060-5 · Cited by 41
Lee, S. S., Vũ, T. T., Weiss, A. S., & Yeo, G. C. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151331 · Cited by 43
Mahato, R. K., Bhattacharya, S., Khullar, N., Sidhu, I. S., Reddy, P. H., Bhatti, G. K., & Bhatti, J. S. (2023) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2023.12.003 · Cited by 40
Taghavi, P., Verhoeven, E., Jacobs, J. J. L., Lambooij, J.-P., Stortelers, C., Tanger, E., Moolenaar, W. H., & van Lohuizen, M. (2008) · Oncogene · doi:10.1038/onc.2008.294 · Cited by 40
Polycomb (PcG) Proteins, BMI1 and SUZ12, Regulate Arsenic-induced Cell Transformation
Kim, H.-G., Kim, D. J., Li, S., Lee, K. Y., Li, X., Bode, A. M., & Dong, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.360362 · Cited by 39
p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
Zeng, Y., Kotake, Y., Pei, X., Smith, M. D., & Xiong, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3483 · Cited by 41
Regenerative Medicine and Stem Cell Based Drug Discovery
Sakurada, K., McDonald, F. M., & Shimada, F. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200700724 · Cited by 40
Epigenetics of hematopoietic stem cell aging and disease
Oshima, M., & Iwama, A. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1647-2 · Cited by 39
Nuclear receptor NR5A2 controls neural stem cell fate decisions during development
Στεργιόπουλος, Α., & Politis, P. K. (2016) · Nature Communications · doi:10.1038/ncomms12230 · Cited by 39
EZH2 Regulates the Developmental Timing of Effectors of the Pre–Antigen Receptor Checkpoints
Jacobsen, J. A., Woodard, J., Mandal, M., Clark, M. R., Bartom, E. T., Sigvardsson, M., & Kee, B. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700319 · Cited by 39
Sienkiewicz, M., Sroka, K., Binienda, A., Jurk, D., & Fichna, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102083 · Cited by 39
Controversial aspects of oncogene-induced senescence
Bianchi, A., & Nikiforov, M. A. (2012) · Cell Cycle · doi:10.4161/cc.22589 · Cited by 39
p16/p53 expression and telomerase activity in immortalized human dental pulp cells
Egbuniwe, O., Idowu, B. D., Funes, J. M., Grant, A. D., Renton, T. F., & Silvio, L. D. (2011) · Cell Cycle · doi:10.4161/cc.10.22.18093 · Cited by 39
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
Marchesi, I., & Bagella, L. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i2.135 · Cited by 38
The impact of ageing mechanisms on musculoskeletal system diseases in the elderly
Cai, Y., Han, Z., Cheng, H., Li, H., Wang, K., Chen, J., Liu, Z., Xie, Y., Lin, Y., Zhou, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405621 · Cited by 51
EBV Latency Programs: Molecular and Epigenetic Regulation and Its Role in Disease Pathogenesis
Lyu, L., Li, Q., & Wang, C. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70501 · Cited by 37
Severson, P. L., Vrba, L., Stampfer, M. R., & Futscher, B. W. (2014) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2014.10.011 · Cited by 37
Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK4a regulation
Martin, N., Popov, N., Aguiló, F., O’Loghlen, A., Raguz, S., Snijders, A. P., Dharmalingam, G., Li, S., Thymiakou, E., Carroll, T. D., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.37 · Cited by 36
Self-citationSavickienė, J., Baronaitė, S., Zentelytė, A., Treigytė, G., & Navakauskienė, R. (2016) · Stem Cells International · doi:10.1155/2016/2019498 · Cited by 39
Poi, M. J., Li, J., Sborov, D. W., VanGundy, Z., Cho, Y. K., Lamprecht, M., Pichiorri, F., Phelps, M. A., & Hofmeister, C. C. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22626 · Cited by 37
Thakur, N., Kupani, M., Mannan, R., Pruthi, A., & Mehrotra, S. (2021) · BMC Medical Genomics · doi:10.1186/s12920-020-00855-1 · Cited by 37
Ottaviano, M., Giunta, E. F., Marandino, L., Tortora, M., Attademo, L., Bosso, D., Cardalesi, C., Fabbrocini, A., Rosanova, M., Silvestri, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10010150 · Cited by 39
p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus
Paulson, T. G., Galipeau, P. C., Xu, L., Kissel, H. D., Li, X., Blount, P. L., Sanchez, C. A., Odze, R. D., & Reid, B. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003809 · Cited by 37
Expression of p14, MDM2, and MDM4 in human retinoblastoma
Guo, Y., Pajovic, S., & Gallie, B. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.055 · Cited by 36
A role for cellular senescence in birth timing
Cha, J. M., & Aronoff, D. M. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1371888 · Cited by 41
DNA damage response(DDR): a link between cellular senescence and human cytomegalovirus
Wu, X., Zhou, X., Wang, S., & Mao, G. (2023) · Virology Journal · doi:10.1186/s12985-023-02203-y · Cited by 41
Negishi, M., Saraya, A., Mochizuki, S., Helin, K., Koseki, H., & Iwama, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012373 · Cited by 37
Bhatia, B., Jiang, M., Suraneni, M. V., Patrawala, L., Badeaux, M. D., Schneider‐Broussard, R., Multani, A. S., Jeter, C. R., Calhoun‐Davis, T., Hu, L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803467200 · Cited by 38
Lee, S. W., Sakakibara, S., Maruo, S., Zhao, B., Calderwood, M. A., Holthaus, A. M., Lai, C.-Y., Takada, K., Kieff, E. D., & Johannsen, E. (2009) · Journal of Virology · doi:10.1128/jvi.01403-09 · Cited by 37
p15 promoter methylation - A novel prognostic marker in glioblastoma patients
Urbschat (2009) · International Journal of Oncology · doi:10.3892/ijo_00000305 · Cited by 36
The nuclear receptor NR2E1/TLX controls senescence
O’Loghlen, A., Martin, N., Krusche, B., Pemberton, H. N., Alonso, M. M., Chandler, H., Brookes, S., Parrinello, S., Peters, G. G., & Gil, J. (2014) · Oncogene · doi:10.1038/onc.2014.335 · Cited by 36
Self-citationWijetunga, N. A., Belbin, T. J., Burk, R. D., Whitney, K. D., Abadi, M. A., Greally, J. M., Einstein, M. H., & Schlecht, N. F. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.006 · Cited by 35
Dynamics of ARF regulation that control senescence and cancer
Ko, A., Han, S. Y., & Song, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.120 · Cited by 35
Churchman, M. L., Roig, I., Jasin, M., Keeney, S., & Sherr, C. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002157 · Cited by 35
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco‐Aparicio, C., Kondoh, H., LLeonart, M. E., Martínez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 36
Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer
Adjiri, A. (2016) · Oncology and Therapy · doi:10.1007/s40487-015-0015-6 · Cited by 39
Sathipati, S. Y., Sahu, D., Huang, H., Lin, Y.-C., & Ho, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-41553-y · Cited by 35
Early growth response 2 (EGR2) is a novel regulator of the senescence programme
Tyler, E. J., del Arroyo, A. G., Wallis, R., Hughes, B., Garbe, J. C., Stampfer, M. R., Koh, J., Lowe, R., Philpott, M. P., & Bishop, C. L. (2021) · Aging Cell · doi:10.1111/acel.13318 · Cited by 34
Wang, C., Zhao, B., Zhai, J., Wang, A., Cao, N., Liao, T., Su, R., He, L., Li, Y., Pei, X., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05843-8 · Cited by 35
Suzuki, T., & Nohara, K. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2765 · Cited by 34
Torchia, E. C., Chen, Y., Sheng, H., Katayama, H. G., Fitzpatrick, J. A. J., Brinkley, W. R., Caulı́n, C., Sen, S., & Roop, D. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1059 · Cited by 35
Persano, L., Moserle, L., Esposito, G., Bronte, V., Barbieri, V., Iafrate, M., Gardiman, M. P., Larghero, P., Pfeffer, U., Naschberger, E., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp052 · Cited by 34
Isayeva, T., Xu, J., Ragin, C. C. R., Dai, Q., Cooper, T. S., Carroll, W. R., Dayan, D., Vered, M., Wenig, B. M., Rosenthal, E. L., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.149 · Cited by 33
Navarro, H. G., Vinué, Á., Sanz, M., Delgado, M., Pozo, M. A., Serrano, M., Burks, D. J., & Andrés, V. (2012) · Aging Cell · doi:10.1111/acel.12023 · Cited by 35
Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis
Rodríguez, E., Quereda, V., Bellutti, F., Prchal‐Murphy, M., Partida, D., Eguren, M., Kollmann, K., de Cedrón, M. G., Dubus, P. R., Cañamero, M., et al. (2014) · Blood · doi:10.1182/blood-2014-02-555292 · Cited by 33
Mehramiz, M., Ghasemi, F., Esmaily, H., Tayefi, M., Hassanian, S. M., Sadeghzade, M., Sadabadi, F., Moohebati, M., Azarpazhooh, M. R., Parizadeh, S. M. R., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.018 · Cited by 33
Gao, P., Si, J., Yang, B., & Yu, J. (2017) · Medical Science Monitor · doi:10.12659/msm.898233 · Cited by 34
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion
Koss, B. S., Shields, B. D., Taylor, E. M., Storey, A. J., Byrum, S. D., Gies, A. J., Washam, C. L., Choudhury, S. R., Ahn, J. H., Uryu, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0524 · Cited by 33
Long Non-Coding RNAs Embedded in the Rb and p53 Pathways
Subramanian, M., Jones, M. F., & Lal, A. (2013) · Cancers · doi:10.3390/cancers5041655 · Cited by 33
Stable Form of JAB1 Enhances Proliferation and Maintenance of Hematopoietic Progenitors
Mori, M., Yoneda‐Kato, N., Yoshida, A., & Kato, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804539200 · Cited by 33
Marchesi, I., Giordano, A., & Bagella, L. (2014) · Cell Cycle · doi:10.4161/cc.27921 · Cited by 33
Allday, M. J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00212 · Cited by 32
Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation
Scruggs, A. M., Koh, H. B., Tripathi, P., Leeper, N. J., White, E. S., & Huang, S. K. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0298oc · Cited by 33
Metadata
- Authors
- Gil, J., & Peters, G.
- Affiliations
- Imperial College London (GB)
- Cancer Research UK (GB)
- Corresponding author
- Peters, Gordon
- ORCID
- Gil, Jesús
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-09-01
- Volume
- 7
- Issue
- 9
- Pages
- 667-677
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2056495027
- Cited by
- 843
- References
- 153
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 24 · 2023: 35 · 2022: 38 · 2021: 30 · 2020: 33 · 2019: 32 · 2018: 35 · 2017: 48 · 2016: 48 · 2015: 53 · 2014: 48 · 2013: 56 · 2012: 58
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- tumor suppressor, CDKN2B, p16INK4a, Arf proteins, cyclin-dependent kinase inhibitors, cis-regulatory elements, replicative senescence, apoptosis, stem cell self-renewal, transcriptional regulation, cancer
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Repressor Proteins, Stem Cells, Signal Transduction, Cellular Senescence, Apoptosis, Cyclin-Dependent Kinase Inhibitor p16, ADP-Ribosylation Factors, Quantitative Trait Loci, Cyclin-Dependent Kinase Inhibitor p15, Polycomb-Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
